Safety/Quality

Latest Issue of OR Manager
September 2024
Home Safety/Quality

FDA clears single-use flexible cystoscope from UroViu

Editor's Note UroViu Corporation, Bellevue, Washington, announced May 24 that it has received clearance from the Food and Drug Administration (FDA) for its portable, flexible single-use cystoscope. The Uro-G has a fully deflectable tip that enables physicians to perform interventional and diagnostic urologic procedures in various settings, without reprocessing.

Read More

By: Judy Mathias
May 27, 2021
Share

CDC: COVID-19 vaccine breakthrough infections

Editor's Note Of 101 million Americans vaccinated against COVID-19 as of April 30, 2021, more than 10,200 had breakthrough infections 14 days or more after receipt of all vaccine doses, according to the Centers for Disease Control and Prevention (CDC). Among these cases: 63% occurred in women 27% were asymptomatic…

Read More

By: Judy Mathias
May 26, 2021
Share

Survey: HCWs report concerns about unsafe working conditions during COVID-19

Editor's Note The George Washington University Milken Institute School of Public Health, in Washington, DC, released a report on May 25 that summarizes findings from a national survey of frontline healthcare workers (HCWs) during the COVID-19 pandemic. The survey of 1,200 HCWs from all 50 states and the District of…

Read More

By: Judy Mathias
May 25, 2021
Share

Risk of COVID-19 transmission via electrocautery plume

Editor's Note In this Canadian experimental study, SARS-CoV-2 was not detectable in aerosolized electrocautery plume generated from any of the conditions investigated. The researchers mimicked surgery by applying electrocautery at 25 W using three different methods (monopolar cut, monopolar coagulate, and bipolar electrocautery) for 1 minute on raw chicken breast.…

Read More

By: Judy Mathias
May 24, 2021
Share

Sponsored Message

CDC recommends Pfizer COVID-19 vaccine for adolescents

Editor's Note The Centers for Disease Control and Prevention (CDC) is recommending that the Pfizer-BioNTech COVID-19 vaccine be given to everyone 12 years of age and older. Previously, COVID-19 vaccines had been authorized only for those aged 16 and older. Pfizer is the first vaccine manufacturer to gain emergency use…

Read More

By: Judy Mathias
May 24, 2021
Share

Effect of duloxetine on opioid use after TKA

Editor's Note Duloxetine was found to be better than placebo for reducing opioid use and was of equal efficacy to placebo for reducing pain after total knee arthroplasty (TKA), in this study presented at the American Society of Regional Anesthesia and Pain Medicine annual meeting, May 13, in Orlando, Florida.…

Read More

By: Judy Mathias
May 20, 2021
Share

Sponsored Message

APIC: CDC’s mask guidelines for fully vaccinated don’t apply to healthcare settings

Editor's Note The Association for Professionals in Infection Control and Epidemiology (APIC) issued guidance on May 14 saying that the Centers for Disease Control and Prevention’s (CDC’s) mask recommendations for those fully vaccinated against COVID-19 do not apply in healthcare settings. Healthcare facilities should continue to follow COVID-19 infection prevention…

Read More

By: Judy Mathias
May 20, 2021
Share

HCWs’ religious, personal convictions behind vaccine avoidance

Editor's Note This study from Vanderbilt University Medical Center (VUMC), Nashville, Tennessee, demonstrates how detailed healthcare workers’ (HCWs’) personal or religious convictions are behind their vaccine avoidance. VUMC requires that all faculty and staff receive the influenza vaccine annually or receive an approved vaccine exemption. All personal and religious exemption…

Read More

By: Judy Mathias
May 20, 2021
Share

ISMP releases perioperative medication safety tool

Editor's Note The Institute for Safe Medication Practices (ISMP), on May 18, released a new perioperative medication safety self assessment to help hospitals, ASCs, and other surgery settings evaluate their medication practices and identify challenges and opportunities for improvement. The tool also offers providers a way to document compliance with…

Read More

By: Judy Mathias
May 20, 2021
Share

Consumer views on use of digital data for COVID-19 control

Editor's Note This survey study of US adults found that many were averse to their information being used on digital platforms to mitigate COVID-19 transmission. Of 6,284 adults surveyed, 3,547 responded, for a completion rate of 56%. Approval was generally low (28% to 43%) for use of consumer digital data…

Read More

By: Judy Mathias
May 19, 2021
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat